We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
401
DELISTED
Noble Energy, Inc.
NBL
| $3.09M | 0.04% |
63,109
+31,381
| +99% | +$1.47M |
|
|
MWV
402
DELISTED
MEADWESTVACO CORP
MWV
| $3.06M | 0.04% |
61,393
+48,439
| +374% | +$2.41M |
|
|
CIR
403
DELISTED
CIRCOR International, Inc
CIR
| $3.06M | 0.04% |
55,895
-9,766
| -15% | -$518K |
|
|
PCH
404
DELISTED
PotlatchDeltic
PCH
| $3.05M | 0.04% |
76,198
-172,748
| -69% | -$6.99M |
|
405
Ormat Technologies
ORA
$6.11B
| $3.05M | 0.04% |
+80,139
| New | +$2.51M |
|
406
Dollar General
DG
$25.9B
| $3.02M | 0.04% |
40,088
+15,153
| +61% | +$1.07M |
|
407
Allison Transmission
ALSN
$10.1B
| $3.01M | 0.04% |
+94,311
| New | +$3.02M |
|
408
Broadcom
AVGO
$1.82T
| $3M | 0.04% |
+236,210
| New | +$2.71M |
|
|
ASRT
409
DELISTED
Assertio
ASRT
| $2.94M | 0.04% |
+2,182
| New | +$2.69M |
|
|
PCYC
410
DELISTED
PHARMACYCLICS INC
PCYC
| $2.93M | 0.04% |
11,438
-96,789
| -89% | -$18.7M |
|
|
FINL
411
DELISTED
Finish Line
FINL
| $2.9M | 0.04% |
+118,428
| New | +$2.85M |
|
412
Teradata
TDC
$2.68B
| $2.9M | 0.04% |
+65,719
| New | +$2.87M |
|
|
WIN
413
DELISTED
Windstream Holdings Inc
WIN
| $2.89M | 0.04% |
49,890
+46,461
| +1,355% | +$2.96M |
|
|
CEMP
414
DELISTED
Cempra, Inc.
CEMP
| $2.88M | 0.04% |
+83,992
| New | +$2.53M |
|
415
Range Resources
RRC
$9.11B
| $2.8M | 0.04% |
53,774
-256,106
| -83% | -$12.7M |
|
|
DATA
416
DELISTED
Tableau Software, Inc.
DATA
| $2.76M | 0.04% |
29,804
-21,935
| -42% | -$1.99M |
|
417
JD.com
JD
$40.8B
| $2.75M | 0.04% |
+93,428
| New | +$2.51M |
|
|
WFT
418
DELISTED
Weatherford International plc
WFT
| $2.72M | 0.04% |
+220,942
| New | +$2.57M |
|
|
OVTI
419
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $2.7M | 0.04% |
102,313
+37,954
| +59% | +$1.02M |
|
420
Terex
TEX
$7.98B
| $2.69M | 0.04% |
+101,371
| New | +$2.56M |
|
421
OraSure Technologies
OSUR
$273M
| $2.69M | 0.04% |
410,534
+394,381
| +2,442% | +$3.28M |
|
422
Constellium
CSTM
$3.96B
| $2.68M | 0.03% |
131,883
| – | – |
|
423
Mueller Water Products
MWA
$3.92B
| $2.68M | 0.03% |
+271,724
| New | +$2.6M |
|
424
Marathon Petroleum
MPC
$90.3B
| $2.66M | 0.03% |
+52,020
| New | +$2.5M |
|
425
Moody's
MCO
$81.7B
| $2.66M | 0.03% |
25,644
+6,847
| +36% | +$662K |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.